$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Novavax: Could It Change the COVID Vaccine Game?
04:51pm, Wednesday, 15'th Jun 2022
Arriving more than two years into the pandemic, here's what Novavax could bring to the immunity table in the US.
Could This News From Moderna Mean Trouble for Novavax?
06:30am, Wednesday, 15'th Jun 2022
Novavax and Moderna both are betting on the booster market.
Novavax' Sees Conditional Approval Of COVID-19 Vaccine Booster In Australia As US FDA Delays Its Decision
11:21am, Monday, 13'th Jun 2022
The Australian regulatory authority has conditionally approved Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine as a booster in individuals aged 18 and over. The provisional re
Should You Worry About Novavax's Latest Delay?
06:00am, Monday, 13'th Jun 2022
Investors may have to wait a bit longer for the big regulatory decision.
Top Biotech Stocks To Invest In Today? 3 To Watch This Week
08:56am, Sunday, 12'th Jun 2022
Should investors be keeping an eye on these movers in the biotech space?
Novavax Stock: Bull vs. Bear
06:04am, Sunday, 12'th Jun 2022
Can this beaten-down vaccine stock make a big comeback?
5 Cutting-Edge Growth Stocks That Can Turn $200,000 Into $1 Million by 2030
05:06am, Sunday, 12'th Jun 2022
These highly innovative growth stocks are begging to be bought by opportunistic investors.
3 Stocks Down 50% or More That You Can Buy Right Now
06:05am, Saturday, 11'th Jun 2022
Huge rebounds could be in store for these beaten-down stocks.
Why Novavax Stock Plummeted on Thursday
04:33pm, Thursday, 09'th Jun 2022
There was some bad news on the regulatory front for the vaccine specialist.
Why Novavax Stock Is Falling Today
09:16am, Thursday, 09'th Jun 2022
Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following reports that the U.S. Food and Drug Administration's decision on the company's COVID-19 vaccine could be delayed to review manuf
FDA decision on Novavax's Covid shots could be delayed to review changes in manufacturing
07:00am, Thursday, 09'th Jun 2022
The FDA's committee recommended the Novavax vaccine for use in the U.S. on Tuesday.
Why Investors Yawned at Novavax's Great FDA Panel News
05:52am, Thursday, 09'th Jun 2022
Novavax still has big hurdles to jump over.
FDA Committee Proposes EUA Nod to Novavax's (NVAX) COVID Jab
03:48pm, Wednesday, 08'th Jun 2022
An FDA advisory committee supports granting emergency use authorization to Novavax's (NVAX) COVID-19 vaccine for use in adults. Post the news, the stock rallies 20% in pre-market trading.
Novavax: EUA Win Reinforces More Positive Outlook For Vaccine Dark Horse
01:54pm, Wednesday, 08'th Jun 2022
Novavax and its COVID vaccine Nuvaxovid was once thought to be a serious challenger to be the first approved COVID vaccine in the US. Yesterday, nearly 550 days after Pfizer / BioNTech's >$50bn sellin
Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval
01:31pm, Wednesday, 08'th Jun 2022
Novavax, Inc (NASDAQ: NVAX) gapped up 10% to start the trading day on Wednesday, but at press time, the stock had given back almost all of its gains to trade mostly flat. The pharmaceutical company's
Sign In
Buy NVAX